Our study suggests a potential link between acetylation and downstream tau processing, which may contribute to the heterogeneous accumulation of N- and C-terminal tau fragments that have been widely detected in mouse and human AD brain as well as CSF from a range of tauopathy patients [31–37]. Here, MAPT is linked to Alzheimer disease.